These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12488654)

  • 1. Diagnostic value of simultaneous non-invasive continuous, ambulatory finger blood pressure and electrocardiogram monitoring in a patient with hypertrophic obstructive cardiomyopathy.
    Boon D; van Goudoever J; Huijskes R; Piek JJ; van Montfrans GA
    Blood Press Monit; 2002 Dec; 7(6):329-33. PubMed ID: 12488654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ST-segment depression in hypertensive patients is linked to elevations in blood pressure, pulse pressure and double product by 24-h Cardiotens monitoring.
    Uen S; Baulmann J; Düsing R; Glänzer K; Vetter H; Mengden T
    J Hypertens; 2003 May; 21(5):977-83. PubMed ID: 12714873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise-induced ST-segment depression and systolic dysfunction in patients with nonobstructive hypertrophic cardiomyopathy.
    Shimizu M; Ino H; Okeie K; Emoto Y; Yamaguchi M; Yasuda T; Fujino N; Fujii H; Fujita S; Mabuchi T; Taki J; Mabuchi H
    Am Heart J; 2000 Jul; 140(1):52-60. PubMed ID: 10874263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cibenzoline on regional left ventricular function in hypertrophic obstructive cardiomyopathy.
    Kondo I; Mizushige K; Nozaki S; Hirao K; Iwado Y; Ohmori K; Matsuo H
    Clin Cardiol; 2000 Sep; 23(9):689-96. PubMed ID: 11016020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upright treadmill vs. semi-supine bicycle exercise echocardiography to provoke obstruction in symptomatic hypertrophic cardiomyopathy: a pilot study.
    Reant P; Dufour M; Peyrou J; Reynaud A; Rooryck C; Dijos M; Vincent C; Cornolle C; Roudaut R; Lafitte S
    Eur Heart J Cardiovasc Imaging; 2018 Jan; 19(1):31-38. PubMed ID: 28329285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hypertrophic cardiomyopathy: relation to pathological mechanisms.
    Kaltenbach M; Hopf R
    J Mol Cell Cardiol; 1985 Jul; 17 Suppl 2():59-68. PubMed ID: 4040978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verapamil therapy in infants with hypertrophic cardiomyopathy.
    Moran AM; Colan SD
    Cardiol Young; 1998 Jul; 8(3):310-9. PubMed ID: 9731645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Episodes of ST-segment depression is related to changes in ambulatory blood pressure and heart rate in intermittent claudication.
    Svensson P; Niklasson U; Ostergren J
    J Intern Med; 2001 Nov; 250(5):398-405. PubMed ID: 11887974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcohol septal ablation in hypertrophic cardiomyopathy utilizing a longitudinal 17-year study (mean 10.8). Observation follow-ups taken at a single medical centre.
    Wojtarowicz A; Kornacewicz-Jach Z
    Cardiol J; 2017; 24(2):125-130. PubMed ID: 27734458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcoronary ablation of septal hypertrophy (TASH): a new treatment option for hypertrophic obstructive cardiomyopathy.
    Kuhn H; Gietzen FH; Leuner C; Schäfers M; Schober O; Strunk-Müller C; Obergassel L; Freick M; Gockel B; Lieder F; Raute-Kreinsen U
    Z Kardiol; 2000; 89 Suppl 4():IV41-54. PubMed ID: 10810776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study of the effects of verapamil and propranolol therapy in 16 cases of obstructive hypertrophic myocardiopathy].
    Cosnay P; Fauchier JP; Lang M; Casset D; Raynaud P; Lavigne G; Itti R
    Arch Mal Coeur Vaiss; 1987 Mar; 80(3):346-55. PubMed ID: 3113357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of biventricular pressure gradients by cibenzo-line in an 18-year-old patient with hypertrophic obstructive cardiomyopathy.
    Hiasa G; Hamada M; Shigematsu Y; Hara Y; Ohtsuka T; Ogimoto A; Saeki H; Suzuki J; Matsunaka T; Hamada H; Okura T; Hiwada K
    Circ J; 2002 Dec; 66(12):1173-5. PubMed ID: 12499627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Echocardiographic and hemodynamic studies on the influence of verapamil in hypertrophic obstructive cardiomyopathy (author's transl)].
    Schmid P; Pavek P; Klein W
    Z Kardiol; 1979 Feb; 68(2):89-92. PubMed ID: 570768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treadmill exercise testing in patients with idiopathic cardiomyopathy (author's transl)].
    Sakamoto S; Yasuda H; Honma H; Kudo T; Mikami T
    Hokkaido Igaku Zasshi; 1980 Jan; 55(1):15-22. PubMed ID: 7190956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chest pain during daily life in patients with hypertrophic cardiomyopathy: an ambulatory electrocardiographic study.
    Elliott PM; Kaski JC; Prasad K; Seo H; Slade AK; Goldman JH; McKenna WJ
    Eur Heart J; 1996 Jul; 17(7):1056-64. PubMed ID: 8809524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise performance in hypertrophic cardiomyopathies.
    Lösse B; Kuhn H; Loogen F; Schulte HD
    Eur Heart J; 1983 Nov; 4 Suppl F():197-208. PubMed ID: 6686536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiarrhythmic drug, cibenzoline, can directly improve the left ventricular diastolic function in patients with hypertrophic cardiomyopathy.
    Hamada M; Shigematsu Y; Hara Y; Suzuki M; Ohtsuka T; Hiasa G; Ogimoto A; Saeki H; Suzuki J; Hiwada K
    Jpn Circ J; 2001 Jun; 65(6):531-8. PubMed ID: 11407736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical aspects, course and prognosis of various forms of hypertrophic cardiomyopathy].
    Kuhn H; Gietzen F; Mercier J; Lösse B; Köhler E; Schulte HD; Bircks W; Loogen F
    Z Kardiol; 1983 Feb; 72(2):83-98. PubMed ID: 6221476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Exercise studies in patients with cardiomyopathy (author's transl)].
    Lösse B; Kuhn H
    Herz; 1982 Apr; 7(2):91-108. PubMed ID: 7200943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential diagnosis of hypertrophic cardiomyopathies: typical (subaortic) hypertrophic obstructive cardiomyopathy, atypical (mid-ventricular) hypertrophic obstructive cardiomyopathy and hypertrophic non-obstructive cardiomyopathy.
    Kuhn H; Mercier J; Köhler E; Frenzel H; Hort W; Loogen F
    Eur Heart J; 1983 Nov; 4 Suppl F():93-104. PubMed ID: 6686549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.